Day One, September 4, 2025 - MT (Mexican Pacific Time, GMT-07:00)
- Callie Mertel - Portfolio Manager, Informa Connect
- Liz Turner - Vice President, Global Market Access, Mirum Pharmaceuticals, Inc.
Begin the conference by looking forward, to try and predict what the market access and patient services functions will look like in the future. Working ahead of the downstream effect, benchmark with organizations on how to optimize market access infrastructure for future headwinds and challenges.
- Discuss the future of medication access and how hub programs are suspected to be utilized
- Hypothesize on the scope and implementation of new roles
- Ensure that your program design remains innovative throughout the coming years
- Josh Marsh - Vice President, General Manager, Cardinal Health Sonexus™ Access & Patient Support
- Gena Murphy - Lead, Patient Services, Global Rare Disease, Chiesi Pharmaceuticals
- Debra Jennings - Head of Patient Services, North America, Kyowa Kirin, Inc.
Delve into the core elements that drive the successful implementation of patient support programs. This session will highlight the foundational strategies and practices that ensure programs are not only launched effectively but also deliver sustained value. Attendees will gain a clear understanding of the essential components that contribute to program success and how to apply them in their own initiatives. Attendees will gain actionable insights into these areas:
- Strategic Planning and Design: explore the importance of thorough planning and design, including setting clear objectives, understanding patient needs and aligning program goals with organizational priorities.
- Integration of Technology and Human Touch: learn how to balance digital tools with human interactions to create a seamless and supportive patient experience that enhances engagement and adherence.
- Continuous Evaluation and Adaptation: discover the significance of ongoing program evaluation and the use of data-driven insights to adapt and refine strategies for continuous improvement and optimal outcomes.
- Josh Konetzni - SVP, Business Development, Momentum Life Sciences
Provide a comprehensive understanding of the existing regulatory landscape governing patient support services and hub models, including OIG guidelines, compliance standards and industry best practices
Gain valuable insights into the latest enforcement actions and the ramifications of recent cases
Uncover the top areas of focus for 2025 and 2026
As the IRA continues to unfold, take a fresh look at how organizations are navigating emerging challenges and patient service shifts while preparing for potential regulatory changes under the new administration. Run through the timeline to learn the effects that the IRA has had on the industry thus far as well as the implementations to come.
- Matt Smith - Principal, VS Health Group
- Jessica Czechowski, PharmD - Director, Clinical Account Services, Prime Therapeutics, State Government Solutions
- Lan Britton - Senior Manager, Trade & Patient Services, SK Life Science Inc
8 months into the new administration, use this session as an opportunity to level-set on the current state of the healthcare industry. As priorities and regulatory agendas are reassessed, uncover the top priorities for industry leaders looking to navigate the evolving market access landscape and better position their organization for long term success.
- Look at key healthcare policies and initiatives that are likely to take shape under the new administration
- Learn how the administration’s approach to pricing, IRA and affordability could impact manufacturers and other stakeholders
- Discover best practices to remain engaged and ahead of everchanging developments
In an era where organizations are inundated with data, effective management is critical to justifying investment and driving impactful patient services and commercial models. Explore best practices for structuring, sharing and optimizing data internally across teams while also ensuring actionable insights for stakeholders and increasing visibility to the patient journey.
- Ensure your organization has a solid data strategy foundation, with an effective data source and/or someone to manage it
- Define strategies to manage data internally, including the varying access levels for different teams, such as commercial, medical, analytics, vendors, etc.
- Learn best practices on how to interpret and segment data, balanced with fast delivery and quality assurance
- Roneil Narciso - Senior Director, Strategic Pricing and Contacting, AVEO Oncology an LG Chem company
- Saurabh Shetti - Director, Data Strategy and Commercial Analytics, Cytokinetics
While patient service programs are not designed to be profit-driven, there is an increased demand for programs to qualitatively and quantitatively show their story. Explore how to effectively use data to demonstrate program success and educate stakeholders on the key outcomes beyond traditional metrics.
- Learn best practices to define and measure your program’s return on objective, as opposed to return on investment
- Identify specific KPIs, and ways to hold your hub program accountable, to deliver on commercial objectives
- Understand how to use data to evaluate and evolve your hub program based on defined objectives
- Rachel Thorpe - Executive Director, Otsuka Patient Assistance Foundation, Inc.
- Irma Lucero - Director, Market Access Account Integration, GSK
- Jay Lavin - Executive Vice President, Partnerships and Business Development, Relay Network
During this session, have an opportunity to level set and gain a deeper, macro-level understanding of how pricing, distribution, copay and all other aspects of your patient support program goes into the GTN calculation and has a downstream effect. Learn non-traditional ways to save money, balance GTN and create a sustainable patient hub.
- Danielle Pettigrew, M.S. - Director, Market Access, Patient Services & Reimbursement, Value, GPO,, Partner Therapeutics
This session explores strategies to develop and implement compliant patient support services for specialty medicines. We'll discuss how to design services that address the unique challenges faced by patients using specialty medications, ensuring that every patient receives the support they need throughout their treatment journey. This session aims to provide insights and best practices for creating compliant patient support services that go above and beyond, ultimately improving patient outcomes and quality of life for those using specialty medicines.
- Kimberly Golynskiy - Senior Director Patient Support Services, Neurocrine Biosciences